-transparent.png){kind=logo}
A patient with a progesterone-producing granulosa cell carcinoma is the basis of this report. Seven years after initial surgical therapy pelvic masses were palpated. At laparotomy the recurrence of tumor was confirmed, and many nonresectable metastases were discovered on the surface of the liver and on the mesentery of the bowel. An exceedingly high plasma progesterone level of 6270 pg/ml was obtained in the postoperative period. During 12 months of single agent chemotherapy with melphalan, serial plasma progesterone assays declined to 310 pg/ml. Complete tumor regression was subsequently confirmed by laparoscopy. Evaluation of progesterone levels in patients with granulosa cell tumors is recommended to determine the incidence of this finding and to further assess its value in following response to therapy.
C W Lomax, and
H V May, and
W B Panko, and
W N Thornton
October 1999,
Molecular and cellular endocrinology,
C W Lomax, and
H V May, and
W B Panko, and
W N Thornton
February 1975,
Rocky Mountain medical journal,
C W Lomax, and
H V May, and
W B Panko, and
W N Thornton
July 1982,
Life sciences,
C W Lomax, and
H V May, and
W B Panko, and
W N Thornton
July 2023,
Biochemical and biophysical research communications,
C W Lomax, and
H V May, and
W B Panko, and
W N Thornton
July 1981,
Molecular and cellular endocrinology,
C W Lomax, and
H V May, and
W B Panko, and
W N Thornton
January 1990,
Reproductive toxicology (Elmsford, N.Y.),
C W Lomax, and
H V May, and
W B Panko, and
W N Thornton
November 1985,
The Journal of clinical endocrinology and metabolism,
C W Lomax, and
H V May, and
W B Panko, and
W N Thornton
June 1999,
Human reproduction (Oxford, England),
C W Lomax, and
H V May, and
W B Panko, and
W N Thornton
January 1985,
Cancer genetics and cytogenetics,
C W Lomax, and
H V May, and
W B Panko, and
W N Thornton
April 2003,
Reproductive biology and endocrinology : RB&E,
